Correlation of the Plasma Concentration of Eltrombopag With Efficacy in the Treatment of Refractory Aplastic Anemia: A Single-Centre Study in China

Background and purpose: Eltrombopag (ELT) can be effective in the treatment of relapse/refractory aplastic anemia (AA) patients. Responses and adverse drug reactions (ADRs) differed greatly among individuals treated at the same dosage of ELT. Methods: Patients diagnosed with nonsevere aplastic anemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Wei, Zhang, Bo, Ruan, Jing, Chen, Miao, Han, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751734/
https://www.ncbi.nlm.nih.gov/pubmed/33364958
http://dx.doi.org/10.3389/fphar.2020.582625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751734/
https://www.ncbi.nlm.nih.gov/pubmed/33364958
http://dx.doi.org/10.3389/fphar.2020.582625

Ejemplares similares